Power Law company profile

Vaxcyte

Biotech & Life Sciences · Foster City, United States · Founded 2013 · IPO 2020 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$6.83B

Market cap · Apr/2026

Investors

12 investors on Vaxcyte's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage

Series B+ 8 investors entered at this stage

Janus Henderson Investors

Foresite Capital

TPG

TPG Growth

RA Capital Management

Medicxi

Pivotal Life Sciences

Frazier Healthcare Partners

Global footprint

Where Vaxcyte has talent and traffic

AI talent share

0.2% of workforce is AI talent
(1 of 527 staff)

Core AI00%

Other AI10.19%

Non-AI workforce52699.81%

Web traffic by country

14K monthly visits
across markets

🇺🇸 United States60%

🇮🇳 India27.9%

🇨🇦 Canada11.4%

🇵🇭 Philippines2.1%

Top 4 markets shown

Patent intelligence

$19M patent portfolio · 18 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with topic prominence vs same-sector peers.

Estimated portfolio value

$19M

0.28% of market cap · 6.7× smaller than top peer Ambrx ($129M)

18 active patent families

Where Vaxcyte innovates Amino acidMolecular biologyImmunogenicityTGE VACCINEPolysaccharide

Tech-focus vs peers

Where Vaxcyte concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Vaxcyte and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Vaxcyte on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo